| Closed |
SWOG-9230 |
Renal |
6/1/1993 |
5/1/1995 |
100% |
|
Published
|
| Closed |
SWOG-8949 |
Renal |
3/1/1991 |
10/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9451 |
Resectable Head and Neck |
4/12/1996 |
12/1/2001 |
87% |
|
Published
|
| Closed |
SWOG-7823/24/25/26 |
ROAP-AdOAP in Acute Adult Leukemia |
8/4/1978 |
9/10/1982 |
|
|
Published
|
| Closed |
S1513 |
RPh II of 2nd Line FOLFIRI w/ or w/o Veliparib (ABT888) in met panc cancer |
9/1/2016 |
|
86% |
|
|
| Closed |
S1613 |
RPh II Pertuzumab+Trastuzumab vs CETIRI mCRC w/HER2 amp |
10/9/2017 |
12/31/2021 |
42% |
|
|
| Closed |
S1304 |
RPII Dex + High or Low Dose Carfilzomib for R/R MM |
10/18/2013 |
5/15/2016 |
100% |
|
|
| Closed |
SWOG-7404 |
RT + CCNU and Procarbazine vs. RT + CCNU Followed by the Sequential Use of Procarbazine after Relapse in Patients with Malignant Gliomas |
6/25/1974 |
3/7/1977 |
|
|
|
| Closed |
SWOG-7703 |
RT in Combination with BCNU, Dimethyl Triazeno Imidazole Carboxamide (DTIC) or Procargazine in Patients with Malignant Gliomas of the Brain |
3/7/1977 |
7/28/1981 |
|
|
Published
|
| Open |
S2200 |
S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2 |
9/19/2022 |
|
10% |
|
|
| Open |
S2007 |
Sacituzumab Govitecan for HER2-Neg Breast Cancer and Brain Metastases |
12/15/2020 |
|
55% |
|
|
| Open |
S2212 |
SCARLET |
7/21/2023 |
|
8% |
|
|
| Closed |
S0216 |
SCCHN |
3/1/2003 |
8/19/2004 |
100% |
|
Published
|
| Closed |
S0826 |
SCH 727965 Stage IV Melanoma |
7/1/2009 |
11/1/2010 |
100% |
|
|
| Closed |
SWOG-8500 |
Second-Line Treatment of Advanced Measurable Ovarian Cancer with CHIP |
8/1/1988 |
11/15/1988 |
|
|
Published
|
| Closed |
S0000 |
SELECT (Selenium and Vitamin E Cancer Prevention Trial) |
7/25/2001 |
6/24/2004 |
100% |
|
Published
|
| Closed |
S0000B |
SELECT Eye Endpoints (SEE) |
7/1/2004 |
7/31/2015 |
|
|
Published
|
| Closed |
SWOG-8810 |
Six Courses of 5-Fluorouracil and Cis-Platinum With Correlation of Clinical and Cellular DNA Parameters in Patients with Advanced, Untreated and Unresectable Squamous Cell Carcinoma of the Head and… |
4/1/1988 |
12/15/1992 |
92% |
|
Published
|
| Closed |
SWOG-9130 |
Smoking Cessation for Early Stage Bladder Cancer Patients Using A Combined Brief Physician-Message and Cancer Information Service (CIS) Counseling Approach |
9/1/1992 |
8/17/1995 |
6% |
|
|
| Closed |
S0002 |
Smoking Cessation Stage I & II NSCLC |
1/1/2002 |
1/1/2004 |
2% |
|
|
